← Leaderboards
Jasdave Chahal
Tiba Biotech, Llc
$3,297,330
Attributed
$3,297,330
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2023–25$2M$1.5M$1M$500K$0
'23
'24
'25
Funding mix
By agency
NIH$3,297,330 · 2
By mechanism
R44$2,898,030 · 1
R43$399,300 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Response”
- Katherine M Thibault · Battelle Memorial Institute$134,148,552
- Angee Greer · Ppd Development Lp$82,531,927
- Richard Smith · Medical Device Innovation Consortium$41,401,350
- Rhea Coler · Seattle Children'S Hospital$35,184,139
- Julia Louise Moore Vogel · Scripps Research Institute, The$32,252,685
- Bridget Murphy · Broad Institute, Inc.$23,600,775
Research focus
ResponseIn VivoInflammatoryProteinsTechnologyMarketingImmunizationImmunogenicityLeadOrganRna VaccineExperimental StudyFormulationMouse ModelCellsImmune ResponseBiotechnologyAntigensInnovationBalb/Cj MouseAvian InfluenzaFlexibilityAcuteEconomics
Grant awards (4)
Rapid response to pandemic influenza via multi-antigen RNA-based vaccine$965,715
R44 · FY2025 · AI · contact PI
Targeted Delivery of Tumor Antigen esaRNA to the Spleen for Cancer Immunotherapy$399,300
R43 · FY2025 · CA · contact PI
Rapid response to pandemic influenza via multi-antigen RNA-based vaccine$965,678
R44 · FY2024 · AI · contact PI
Rapid response to pandemic influenza via multi-antigen RNA-based vaccine$966,637
R44 · FY2023 · AI · contact PI